SCHEMBL26556

SCHEMBL26556

c1cc(Oc2ccnnn2)nnn1

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL134811 0.81
SCHEMBL6265002 0.80
Hydrochloric Acid SCHEMBL9616927 0.79
SCHEMBL8568961 0.79
SCHEMBL3172913 0.79
SCHEMBL5686802 0.79 MEN1 (0.48) MEN1KMT2AHTT
SCHEMBL5586068 0.79 ALDH1A1 (0.48) MEN1KMT2AALDH1A1
SCHEMBL9005317 0.78
SCHEMBL6827266 0.76 ALOX15 (0.34) ALDH1A1
SCHEMBL6267051 0.76 RAB9A (0.39) MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12297383-B2 Condensed polycyclic conjugated polymers and their use for biological detection AAT BIOQUEST, INC. (US) 2025-05-13 US claimed
US-20240052238-A1 CONDENSED POLYCYCLIC CONJUGATED POLYMERS AND THEIR USE FOR BIOLOGICAL DETECTION AAT BIOQUEST, INC. (US) 2024-02-15 US claimed
US-11827824-B2 Condensed polycyclic conjugated polymers and their use for biological detection AAT BIOQUEST, INC. (US) 2023-11-28 US claimed
US-20230131000-A1 UV Excitable Polyfluorene Based Conjugates and Their Use in Methods of Analyte Detection AAT BIOQUEST, INC. 2023-04-27 US claimed
EP-4097477-A1 UV EXCITABLE POLYFLUORENE BASED CONJUGATES AND THEIR USE IN METHODS OF ANALYTE DETECTION Aat Bioquest, Inc. (US) 2022-12-07 EP claimed
CN-115280147-A UV excitable polyfluorene-based conjugates and their use in analyte detection methods 阿特生物探索公司 2022-11-01 CN claimed
US-20220089943-A1 CONDENSED POLYCYCLIC CONJUGATED POLYMERS AND THEIR USE FOR BIOLOGICAL DETECTION AAT BIOQUEST, INC. 2022-03-24 US claimed
US-11220628-B2 Condensed polycyclic conjugated polymers and their use for biological detection AAT BIOQUEST, INC. (US) 2022-01-11 US claimed
EP-3219712-B1 COUMARIN DYES AND CONJUGATES THEREOF CYANAGEN SRL (IT) 2021-08-18 EP claimed
WO-2021154933-A1 UV EXCITABLE POLYFLUORENE BASED CONJUGATES AND THEIR USE IN METHODS OF ANALYTE DETECTION AAT BIOQUEST, INC. (US) 2021-08-05 WO claimed
US-20180171070-A1 Polyfluoreno[4,5-cde]oxepine Conjugates and Their Use in Methods of Analyte Detection AFFYMETRIX, INC. 2018-06-21 US claimed
US-9896538-B2 Polyfluoreno[4,5-cde]oxepine polymers and conjugates thereof AAT BIOQUEST, INC. (US) 2018-02-20 US claimed
WO-2017172608-A1 POLYFLUORENO[4,5-CDE]OXEPINE CONJUGATES AND THEIR USE IN METHODS OF ANALYTE DETECTION AAT BIOQUEST, INC. (US) 2017-10-05 WO claimed
US-20170275418-A1 Polyfluoreno[4,5-cde]oxepine Conjugates and Their Use in Methods of Analyte Detection AAT BIOQUEST, INC. 2017-09-28 US claimed
US-20170267866-A1 NOVEL COUMARIN DYES AND CONJUGATES THEREOF CYANAGEN S.R.L. (IT) 2017-09-21 US claimed
EP-3219712-A1 COUMARIN DYES AND CONJUGATES THEREOF Cyanagen Srl (IT) 2017-09-20 EP claimed
US-8168052-B2 Transition metal complexes with bidentate ligand having an imidazole ring ABBOTT DIABETES CARE INC. (US) 2012-05-01 US claimed
US-20100288634-A1 Transition Metal Complexes with Bidentate Ligand Having an Imidazole Ring ABBOTT DIABETES CARE INC. 2010-11-18 US claimed
EP-0629192-A1 HERBICIDALLY ACTIVE PYRIMIDINYL AND TRIAZINYL COMPOUNDS CIBA-GEIGY AG (CH) 1994-12-21 EP claimed
WO-1994010156-A1 HERBICIDALLY ACTIVE PYRIMIDINYL AND TRIAZINYL COMPOUNDS CIBA-GEIGY AG (CH) 1994-05-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131000-A1 UV Excitable Polyfluorene Based Conjugates and Their Use in Methods of Analyte Detection PARG, SLC46A1, PARN MEN1 1180/4885KMT2A 2644/4885ALDH1A1 372/4885
US-20170267866-A1 NOVEL COUMARIN DYES AND CONJUGATES THEREOF IK, CYP3A7, HCCS MEN1 3048/4885KMT2A 4521/4885ALDH1A1 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.